The ACTG2 gene gives your body instructions for a protein that helps smooth muscle cells squeeze, especially in the intestines and bladder. If it does not work properly, these muscles may move weakly, which can lead to severe constipation, belly swelling, feeding problems, bowel blockage without a physical blockage, or trouble emptying the bladder. This gene plays an important role in the wave-like movements that push food and waste through the gut. Pathogenic variants in the ACTG2 gene can cause an inherited condition affecting smooth muscle in the digestive and urinary tracts.
What is a gene?
Each gene is a stretch of DNA that holds information your cells use to make molecules or regulate processes in the body. Some genes provide the instructions for making proteins, which are the working parts of cells. Other genes mainly direct when certain processes happen, where they happen, and how strongly they occur. Together, genes affect how the body develops and functions, and they can shape how you respond to food, stress, and medications. For a deeper look at this topic, you can read more in the LearnHub.
Overview
ACTG2Gene function
What if the gene works
The ACTG2 gene helps make a protein used in smooth muscle, especially in the intestines and bladder. This supports steady squeezing movements that move food, waste, and urine along.
Risk
What if the gene does not work
Variants in the ACTG2 gene can disrupt smooth muscle movement in the intestines and bladder. Effects range from milder bowel problems to earlier, wider involvement with an enlarged bladder and very poor movement through the gut.
Treatment
What does that mean for your treatment
For pathogenic variants in the ACTG2 gene, no ACTG2-specific treatment or drug choice is currently established.
Conditions associated with ACTG2
Gene function
What if the gene works
Your body uses the ACTG2 gene to help smooth muscle cells create the fibers that let hollow organs move in a controlled way. These muscles line places like the intestines, stomach, bladder, and uterus, where steady squeezing matters all day. Understanding how the ACTG2 gene works can make it easier to see how smooth muscle cells contract in the bowel and bladder.
The ACTG2 gene helps smooth muscle cells build thin fibers that form part of their internal pulling system. These fibers give cells the basic equipment needed for steady squeezing in organs such as the bowel and bladder.
Its protein works with partner proteins so smooth muscle cells can shorten and relax in a controlled rhythm. This supports the smooth muscle contraction that moves food, fluid, and waste through hollow organs.
The ACTG2 gene also helps these muscle cells keep their shape while they stretch and contract. That support lets the tissue stay stable during routine pressure and movement throughout the day.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help account for normal differences among people, such as appearance, metabolism, or the way the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
ACTG2 gene variants can alter the shape or behavior of the actin protein, so smooth muscle cells build weaker or disorganized contractile fibers. This explains how ACTG2 gene variants affect smooth muscle: some milder changes partly reduce filament assembly or protein stability, while more severe variants can strongly disrupt interactions within the cell’s contraction machinery. Greater disruption is often linked with earlier and more extensive bowel and bladder muscle involvement.
How variants are linked to conditions
Pathogenic variants in the ACTG2 gene are best known for causing ACTG2 visceral myopathy, a condition that can affect movement of the intestines and bladder. This can present as chronic intestinal pseudo-obstruction or, in more severe cases, megacystis-microcolon-intestinal hypoperistalsis syndrome. Some people with ACTG2 gene related intestinal and bladder problems have milder symptoms that vary within families. A confirmed pathogenic variant in the ACTG2 gene can help establish the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply reflect natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when more than one gene and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific lifestyle or environmental factors that increase or reduce health risks linked to the ACTG2 gene. For many living with an ACTG2 change, risk is shaped mainly by the variant itself and family history, while symptoms can still vary a lot from one person to another.
Inheritance of ACTG2 variants
ACTG2-related conditions are usually inherited in an autosomal dominant pattern. That means a parent with an ACTG2 gene variant can pass it to each child with a 50% chance. In some families, the variant is inherited across generations, while in other people it appears for the first time as a new, de novo change that was not inherited from either parent. When people ask how variants of the ACTG2 gene are inherited, the usual answer is autosomal dominant inheritance, with de novo cases also well recognized.
What does my ACTG2 result mean for my family?
For ACTG2, a disease-causing result is most often linked to a dominant pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same change. If a parent carries it, each child has a 1 in 2 chance of inheriting it. Some ACTG2 changes happen new in the affected person, so a parent does not always have the same result.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for ACTG2 variants uses a blood or saliva sample to read the ACTG2 gene and look for variants. It can help clarify whether an inherited gene change may be contributing to bowel or bladder movement problems and whether the same variant is present in other family members.
When should I consider getting a genetic test?
Consider ACTG2 testing if you or your child has serious long-term problems with how the intestines and bladder squeeze and move, such as repeated bowel blockage without a true blockage, severe constipation from birth, or a very enlarged bladder. It can also be useful when similar problems run in the family.
A genetic result is only one part of your health story
A genetic test result can be informative, but how much it explains depends on the condition and the kind of variant involved. Over time, factors such as age, lifestyle, environment, and medical history also influence how the body works. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most useful when considered with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, it can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles certain medicines. This helps explain why the same drug may work well for one person, have less effect in another, or cause more side effects in someone else. These differences are common and may influence how quickly a medicine is processed, how strongly it acts, or how sensitive your body is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medicines. By looking at links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body processes it. This information can support treatment decisions that are more informed and more personalized. You can read more about this topic in the LearnHub.
Drugs influenced by the ACTG2 gene
When should I seek medical advice?
There is no broadly confirmed evidence that changes in this gene affect how medicines work, so questions about medication response, side effects, or other health concerns are best discussed with your doctor.
History
ACTG2 entered medical genetics more recently than some better known genes. In recent decades, awareness of this gene’s role has grown as researchers studying rare inherited conditions affecting the intestines and bladder looked for a shared genetic cause. A major step came in the 2010s, when pathogenic variants in the ACTG2 gene were identified in families with visceral myopathy and in children with megacystis microcolon intestinal hypoperistalsis syndrome. That finding helped connect several conditions that had previously been described mainly by their symptoms. From these first observations, research expanded steadily. The way this gene was viewed has shifted over time, from a gene of basic muscle biology to one with clear importance in clinical genetics.